CM
Crestline Management Portfolio holdings
AUM
$62.6M
This Quarter Return
+25.63%
1 Year Return
-18.06%
3 Year Return
+16.7%
5 Year Return
+67.08%
10 Year Return
+99.86%
AUM
$745M
AUM Growth
+$745M
(+36%)
Cap. Flow
+$66.7M
Cap. Flow
% of AUM
8.96%
Top 10 Holdings %
Top 10 Hldgs %
76.65%
Holding
188
New
74
Increased
30
Reduced
20
Closed
60
Top Buys
| 1 |
MON
Monsanto Co
MON
|
$6.27M |
| 2 |
Verisk Analytics
VRSK
|
$5.84M |
| 3 |
Air Products & Chemicals
APD
|
$4.65M |
| 4 |
DNB
Dun & Bradstreet
DNB
|
$4.61M |
| 5 |
Honeywell
HON
|
$4.13M |
Top Sells
| 1 |
FNB Corp
FNB
|
$5.24M |
| 2 |
Dover
DOV
|
$4.9M |
| 3 |
Associated Banc-Corp
ASB
|
$3.9M |
| 4 |
KeyCorp
KEY
|
$3.73M |
| 5 |
PACW
PacWest Bancorp
PACW
|
$2.8M |
Sector Composition
| 1 | Financials | 12.57% |
| 2 | Healthcare | 6.09% |
| 3 | Industrials | 5.44% |
| 4 | Materials | 3.11% |
| 5 | Technology | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Kirby Corp
KEX
$4.95B
| $707K | 0.09% |
10,582
-20,608
| -66% | -$1.38M |
|
102
Radian Group
RDN
$4.74B
| $694K | 0.09% |
+42,416
| New | +$694K |
|
103
Zimmer Biomet
ZBH
$20.8B
| $693K | 0.09% |
5,562
-5,444
| -49% | -$678K |
|
104
Moody's
MCO
$89B
| $661K | 0.09% |
+5,434
| New | +$661K |
|
105
HCA Healthcare
HCA
$95.4B
| $629K | 0.08% |
+7,209
| New | +$629K |
|
106
Herc Holdings
HRI
$4.2B
| $619K | 0.08% |
15,733
-44,621
| -74% | -$1.76M |
|
107
Manitowoc
MTW
$351M
| $601K | 0.08% |
24,986
-86,265
| -78% | -$2.07M |
|
108
Louisiana-Pacific
LPX
$6.48B
| $593K | 0.08% |
+24,607
| New | +$593K |
|
|
DERM
109
DELISTED
Dermira, Inc.
DERM
| $580K | 0.08% |
19,917
+1,737
| +10% | +$50.6K |
|
110
Morgan Stanley
MS
$237B
| $561K | 0.08% |
+12,579
| New | +$561K |
|
111
Heron Therapeutics
HRTX
$204M
| $513K | 0.07% |
+37,020
| New | +$513K |
|
112
Akebia Therapeutics
AKBA
$827M
| $504K | 0.07% |
+35,098
| New | +$504K |
|
113
IES Holdings
IESC
$6.8B
| $437K | 0.06% |
+24,077
| New | +$437K |
|
|
BCPC
114
Balchem Corporation
BCPC
$5.21B
| $432K | 0.06% |
5,557
-7,280
| -57% | -$566K |
|
|
GNMK
115
DELISTED
GenMark Diagnostics, Inc
GNMK
| $426K | 0.06% |
+36,046
| New | +$426K |
|
|
FRTA
116
DELISTED
Forterra, Inc
FRTA
| $348K | 0.05% |
+42,330
| New | +$348K |
|
|
SIOX
117
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $334K | 0.04% |
+1,802
| New | +$334K |
|
118
Iovance Biotherapeutics
IOVA
$800M
| $318K | 0.04% |
+43,254
| New | +$318K |
|
|
BKI
119
DELISTED
Black Knight, Inc. Common Stock
BKI
| $302K | 0.04% |
+7,376
| New | +$302K |
|
|
PACW
120
DELISTED
PacWest Bancorp
PACW
| $280K | 0.04% |
6,000
-60,000
| -91% | -$2.8M |
|
121
Brown & Brown
BRO
$31.4B
| $273K | 0.04% |
+12,664
| New | +$273K |
|
|
DBVT
122
DBV Technologies
DBVT
$249M
| $257K | 0.03% |
+721
| New | +$257K |
|
|
ARAV
123
DELISTED
Aravive, Inc. Common Stock
ARAV
| $252K | 0.03% |
+2,403
| New | +$252K |
|
|
124
FNB Corp
FNB
$5.92B
| $227K | 0.03% |
16,000
-369,000
| -96% | -$5.24M |
|
125
Incyte
INCY
$17B
| $227K | 0.03% |
1,802
-5,313
| -75% | -$669K |
|